Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | OXY | CNQ |
|---|---|---|
| Price | $58.11 | $48.30 |
| Change today | ▲ 1.31% | ▲ 1.37% |
| Market cap | $58.09B | $99.56B |
| Return, 3 months | +14.3% | +23.8% |
| Return, year to date | +43.3% | +46.9% |
| Return, 1 year | +26.4% | +53.6% |
| P/E (TTM) | 9.0 | 12.1 |
| P/B | 1.7 | 3.0 |
| P/E percentile vs own 5y | 34th | 52nd |
| Dividend yield | 1.72% | 3.54% |
| Revenue growth (YoY, latest qtr) | +53.4% | +77.9% |
| Net profit growth (YoY) | +540.2% | +83.1% |
| Gross margin | 41.8% | 26.3% |
| Operating margin | 25.8% | 23.2% |
| Net margin | 27.3% | 22.9% |
| Return on equity | 21.5% | 26.7% |
| Analyst target vs. price | +14.7% | +9.0% |
| Analyst buy share | 40% | 44% |
| RSI (14) | 44 | 46 |
| 30-day volatility | 30.0% | 26.4% |
| Max drawdown, 1 year | -27.3% | -21.5% |
| Trend read | Leaning bearish | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.